Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab

S. Tischer-Zimmermann, A. Bonifacius, M. Santamorena, P. Mausberg, S. Stoll, M. Döring, U. Kalinke, R. Blasczyk, B. Maecker-Kolhoff, and B. Eiz-Vesper. Front Immunol, (March 2023)
DOI: 10.3389/fimmu.2023.878953

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Thomas Kalinke

Ulrich Kalinke

Thomas Kalinke

Else Kalinke

Sabine Kalinke

Other publications of authors with the same name

Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTLA. Pilz, W. Kratky, S. Stockinger, O. Simma, U. Kalinke, K. Lingnau, A. von Gabain, D. Stoiber, V. Sexl, T. Kolbe and 16 other author(s). J Immunol, 183 (4): 2286-2293 (2009)A combination of a common splice site mutation and a frameshift mutation in the COL7A1 gene: absence of functional collagen VII in keratinocytes and skinN. Hammami-Hauasli, D. Kalinke, H. Schumann, U. Kalinke, B. Pontz, I. Anton-Lamprecht, L. Pulkkinen, M. Zimmermann, J. Uitto, and L. Bruckner-Tuderman. J Invest Dermatol, 109 (3): 384-389 (1997)Collagen VII in severe recessive dystrophic epidermolysis bullosa: expression of mRNA but lack of intact protein product in skin and cutaneous cells in vitroD. Kalinke, U. Kalinke, J. Winberg, A. Konig, J. Lauharanta, A. Christiano, J. Uitto, and L. Bruckner-Tuderman. J Invest Dermatol, 102 (2): 260-262 (1994)Regulation of antiviral T cell responses by type I interferonsJ. Crouse, U. Kalinke, and A. Oxenius. Nat Rev Immunol, 15 (4): 231-242 (2015)A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearanceH. Wang, S. El Maadidi, J. Fischer, E. Grabski, S. Dickhofer, S. Klimosch, S. Flannery, A. Filomena, O. Wolz, N. Schneiderhan-Marra and 13 other author(s). Hepatol, 62 (5): 1375-1387 (2015)Ultrasensitive quantification of TAP-dependent antigen compartmentalization in scarce primary immune cell subsetsH. Fischbach, M. Doring, D. Nikles, E. Lehnert, C. Baldauf, U. Kalinke, and R. Tampe. Nat Commun, (2015)Infection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulationE. Waffarn, C. Hastey, N. Dixit, Y. Choi, S. Cherry, U. Kalinke, S. Simon, and N. Baumgarth. Nature Communications, (2015)CD4+ T cells in patients with chronic inflammatory rheumatic disorders show distinct levels of exhaustionT. Frenz, E. Grabski, D. Buschjäger, L. Vaas, N. Burgdorf, R. Schmidt, T. Witte, and U. Kalinke. J Allergy Clin Immunol, 138 (2): 586-589 e10 (2016)Poly(I:C)-Encapsulating Nanoparticles Enhance Innate Immune Responses to the Tuberculosis Vaccine Bacille Calmette–Guérin (BCG) via Synergistic Activation of Innate Immune ReceptorsM. Speth, U. Repnik, E. Müller, J. Spanier, U. Kalinke, A. Corthay, and G. Griffiths. Mol Pharm, 14 (11): 4098-4112 (2017)PMID: 28974092.Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus AnkaraH. Ludwig, Y. Suezer, Z. Waibler, U. Kalinke, B. Schnierle, and G. Sutter. J Gen Virol, 87 (Pt 5): 1145-1155 (2006)

BibSonomy

Disambiguation of "Kalinke, U"

Please choose a person to relate this publication to

Thomas Kalinke

Ulrich Kalinke

Thomas Kalinke

Else Kalinke

Sabine Kalinke

Other publications of authors with the same name

Disambiguation

BibSonomy

Disambiguation of "Kalinke, U"

copydeleteadd this publication to your clipboardcommunity posthistory of this postURLDOIBibTeXEndNoteAPAChicagoDIN 1505HarvardMSOffice XML Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab

Please choose a person to relate this publication to

Thomas Kalinke

Ulrich Kalinke

Thomas Kalinke

Else Kalinke

Sabine Kalinke

Other publications of authors with the same name

Disambiguation